Tilak Healthcare develops OdySight®, a clinically validated mobile application that enables patients with chronic retinal diseases to monitor their vision from home through engaging medical games. This platform enhances patient-doctor communication and optimizes treatment management by providing reliable, remote visual assessments.
Funding
$26.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CIFounders
Product
Problem
Patients with chronic retinal diseases need regular monitoring to track vision changes, but traditional methods often require frequent visits to specialized clinics. Existing self-monitoring solutions, like the Amsler grid, have proven to be unreliable for consistent and accurate tracking of disease progression.
Solution
Tilak Healthcare offers OdySight®, a clinically validated mobile application that enables patients with chronic retinal conditions to monitor their vision from home. The platform uses engaging medical games to assess visual parameters, providing a more interactive and user-friendly experience compared to traditional methods. OdySight® enhances communication between patients and doctors by providing reliable, remote visual assessments, which can lead to optimized treatment management and timely intervention. The app is available via prescription from an ophthalmologist and is designed to monitor visual parameters in patients with chronic maculopathies.
Target Audience
The primary target audience includes ophthalmologists and their patients with chronic retinal diseases, such as age-related macular degeneration and diabetic retinopathy, who require regular vision monitoring.
Features
- Medical-grade mobile games designed to assess key visual parameters relevant to retinal diseases.
- Clinically validated for remote monitoring of chronic maculopathies.
- Enhances patient-doctor communication through reliable, objective data.
- Gamified experience to improve patient engagement and adherence to testing schedules.
- Data-driven insights to optimize treatment management and personalize care.
- Compliant with ISO 13485:2016 quality management system standards.